14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Oct 11, 2019 $3.13 $3.23 $3.05 $3.06 70 125
Oct 10, 2019 $3.11 $3.25 $3.06 $3.15 63 311
Oct 09, 2019 $3.29 $3.47 $3.07 $3.12 112 479
Oct 08, 2019 $3.31 $3.43 $3.28 $3.28 92 915
Oct 07, 2019 $3.53 $3.66 $3.33 $3.37 109 759
Oct 04, 2019 $3.70 $3.79 $3.52 $3.53 102 293
Oct 03, 2019 $3.97 $4.01 $3.70 $3.70 106 301
Oct 02, 2019 $4.10 $4.18 $3.96 $4.00 184 540
Oct 01, 2019 $4.19 $4.24 $3.93 $4.14 140 000
Sep 30, 2019 $4.00 $4.24 $3.70 $4.16 451 633
Sep 27, 2019 $4.45 $4.61 $3.73 $3.99 3 140 164
Sep 26, 2019 $3.77 $4.01 $3.70 $4.00 126 741
Sep 25, 2019 $3.76 $3.80 $3.61 $3.78 117 376
Sep 24, 2019 $3.52 $3.82 $3.30 $3.75 149 069
Sep 23, 2019 $3.49 $3.70 $3.27 $3.64 90 132
Sep 20, 2019 $3.62 $3.62 $3.35 $3.42 69 899
Sep 19, 2019 $3.77 $3.81 $3.58 $3.61 52 206
Sep 18, 2019 $3.79 $3.84 $3.69 $3.80 58 803
Sep 17, 2019 $3.92 $3.92 $3.68 $3.78 87 606
Sep 16, 2019 $3.71 $3.88 $3.60 $3.85 102 377
Sep 13, 2019 $3.71 $3.81 $3.66 $3.68 128 201
Sep 12, 2019 $3.74 $3.85 $3.38 $3.73 116 888
Sep 11, 2019 $3.84 $3.86 $3.68 $3.70 118 258
Sep 10, 2019 $3.80 $4.03 $3.67 $3.78 218 712
Sep 09, 2019 $3.87 $4.02 $3.76 $3.80 96 286
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT